NVOon logo

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The...

NYSEHealthcareDrug Manufacturers - GeneralUSA

公司简介

股票代码
NVO
ISIN代码
US6701002056
货币
US Dollar (USD)
IPO日期
1982-01-04

联系信息

公司地址
Novo Alle 1, Bagsvaerd, Denmark, 2880
联系电话
45 44 44 88 88
公司网站
https://www.novonordisk.com
财年结束
December

财务亮点

市值
$999,999.99
毛利润(TTM)
$999,999.99
股息收益率
4.07%
资产回报率(TTM)
19.25%
EBITDA
$999,999.99
收入(TTM)
$999,999.99